Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Trial details
- Registry ID
- NCT07075718
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Timolol maleate ophthalmic solution, 0.5%
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07075718 | Glaukos Corporation | Phase 2 | Recruiting | 2028-03Estimated |
| Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07495852 | Glaukos Corporation | Phase 3 | Recruiting | 2028-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |